INOZYME PHARMA INC's ticker is INZY and the CUSIP is 45790W108. A total of 80 filers reported holding INOZYME PHARMA INC in Q4 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $94 | -66.7% | 21,233 | -42.5% | 0.00% | – |
Q1 2024 | $282 | -4.4% | 36,909 | -46.6% | 0.00% | – |
Q4 2023 | $295 | +656.4% | 69,124 | +649.7% | 0.00% | – |
Q3 2023 | $39 | -30.4% | 9,220 | -9.7% | 0.00% | – |
Q2 2023 | $56 | +55.6% | 10,205 | +62.7% | 0.00% | – |
Q1 2023 | $36 | +414.3% | 6,273 | 0.0% | 0.00% | – |
Q4 2022 | $7 | -100.0% | 6,273 | -2.0% | 0.00% | – |
Q3 2022 | $17,000 | -45.2% | 6,403 | 0.0% | 0.00% | – |
Q2 2022 | $31,000 | -13.9% | 6,403 | -26.7% | 0.00% | – |
Q1 2022 | $36,000 | – | 8,740 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pivotal bioVenture Partners Investment Advisor LLC | 1,591,154 | $27,113,000 | 10.69% |
Burrage Capital Management LLC | 242,517 | $4,132,000 | 4.14% |
CHI Advisors LLC | 927,264 | $15,801,000 | 3.68% |
Sofinnova Investments, Inc. | 2,028,308 | $34,562,000 | 1.99% |
Novo Holdings A/S | 1,867,706 | $31,826,000 | 1.41% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,178,985 | $37,130,000 | 0.66% |
RA Capital Management | 2,003,653 | $34,142,000 | 0.55% |
NEA Management Company, LLC | 2,444,379 | $41,652,000 | 0.54% |
Rock Springs Capital Management LP | 840,272 | $14,318,000 | 0.28% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 365,172 | $6,223,000 | 0.09% |